antimycin a has been researched along with Acute Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Centonze, VE; Chen, T; Downing, JR; Fan, Y; Fukuda, Y; Ge, Y; Gruber, TA; Kriwacki, R; Lin, H; Lin, W; Ma, J; Naren, AP; Nourse, A; Peters, JL; Phillips, AH; Pitre, A; Schuetz, JD; Sinha, C; Temirov, J; Wang, Y | 1 |
| Akers, LJ; Fang, W; Franklin, AR; Huang, P; Levy, AG; Zweidler-McKay, PA | 1 |
| Bradsher, RW; Davis, JP; Klein, BS; Vergeront, JM | 1 |
3 other study(ies) available for antimycin a and Acute Disease
| Article | Year |
|---|---|
An unexpected protein interaction promotes drug resistance in leukemia.
Topics: Acute Disease; Animals; Antimycin A; Blood Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; HEK293 Cells; Hematopoietic Stem Cells; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid; Membrane Proteins; Mice; Multidrug Resistance-Associated Proteins; Protein Binding | 2017 |
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin.
Topics: Acute Disease; Adenosine Triphosphate; Antimycin A; Apoptosis; Caspase 3; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Glycolysis; HL-60 Cells; Humans; Hydrocarbons, Brominated; Immunoblotting; Jurkat Cells; Leukemia; Propionates; Sirolimus; Time Factors; U937 Cells | 2011 |
Development of long-term specific cellular immunity after acute Blastomyces dermatitidis infection: assessments following a large point-source outbreak in Wisconsin.
Topics: Acute Disease; Antigens, Fungal; Antimycin A; Blastomycosis; Child; Disease Outbreaks; Female; Follow-Up Studies; Humans; Immunity, Cellular; Lymphocyte Activation; Male; Skin Tests; Wisconsin | 1990 |